Amanda Maguschak, CNP
Nurse Practitioner in Worcester, Massachusetts. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 87,227 in Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amanda Maguschak, CNP reported a CMS MIPS final score of 59/100 - below the 83.1 national average - and filed 299 Medicare Part D claims in 2023.
- 59/100
- MIPS score · -24 vs avg
- 299
- Part D claims, 2023
- 56%
- generic prescribing
- $22.83
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Amanda Maguschak, CNP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
59 5th percentile higher than 5% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amanda Maguschak, CNP sits
This provider among nurse practitioner peers
Across the 13,476 nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Amanda Maguschak, CNP writes more Part D claims than 44% of them and scores higher on MIPS quality than 3% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nurse practitioner peer from a representative sample of 60; the gold marker is Amanda Maguschak, CNP. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Amanda Maguschak, CNP?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Nurse Practitioner compares to other specialties among Massachusetts providers
Nurse Practitioner ranks #18 among Massachusetts's specialties (1.5% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Amanda Maguschak, CNP's 2023 MIPS final score plotted against the Nurse Practitioner national average
- MIPS Final Score
- 59/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nurse Practitioner) - 59/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Nurse Practitioner US NPIs
59/100 MIPS final score - 24.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Nurse Practitioner. Quality dim: 17.9. Cost dim: 57.4.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Amanda Maguschak, CNP appears in the CMS NPPES registry as a Nurse Practitioner provider holding CNP credentials at 55 LAKE AVE N, Worcester, MA, 01655, with a listed phone of (508) 856-2846. NPI 1417478249 was issued on 07/01/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Maguschak most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 299 prescription claims written by this provider, covering 99 Medicare beneficiaries and totaling roughly $249K in drug spend, split 44% brand-name and 56% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 59/100 for the 2023 performance year (Quality 17.9, Cost 57.4), compared with the national average of 83.1.
Nurse Practitioner is a high-volume specialty nationwide, with 87,227 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1417478249 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | CNP |
| Gender | Female |
| NPI Issued | 07/01/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Amanda Maguschak, CNP's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amanda Maguschak, CNP. Source: openpaymentsdata.cms.gov.
Total received
$23
Largest payer
Braeburn Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Amanda Maguschak, CNP. To verify Amanda Maguschak, CNP's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 56% generic, on 299 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 489
- Total Day Supply
- 14,407
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $242K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 63.4 years
- Avg HCC Risk Score
- 2.35
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 47, 65-74: 27, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amanda Maguschak, CNP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Creon
Creon
81 claims
- Omeprazole
Omeprazole
42 claims
- Pantoprazole Sodium
Pantoprazole Sodium
35 claims
- Linzess 21
Linzess
21 claims
- Famotidine 17
Famotidine
17 claims
- Dicyclomine Hcl 13
Dicyclomine Hcl
13 claims
- Lubiprostone 12
Lubiprostone
12 claims
| Drug | Claims |
|---|---|
| Creon Lipase/Protease/Amylase | 81 |
| Omeprazole | 42 |
| Pantoprazole Sodium | 35 |
| Linzess Linaclotide | 21 |
| Famotidine | 17 |
| Dicyclomine Hcl | 13 |
| Lubiprostone | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How Amanda Maguschak, CNP fits within the Nurse Practitioner landscape nationally.
Amanda Maguschak, CNP's 299 claims are below the specialty average of 1,084.
Nearby Nurse Practitioner Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Maguschak.
Compare Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Massachusetts medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is Amanda Maguschak, CNP's specialty? ▼
How much does Amanda Maguschak, CNP prescribe under Medicare Part D? ▼
What is Amanda Maguschak, CNP's Medicare quality score? ▼
Where is Amanda Maguschak, CNP located? ▼
What is Amanda Maguschak, CNP's NPI number? ▼
Does Amanda Maguschak, CNP prescribe more brand-name or generic drugs? ▼
How many Nurse Practitioner providers are there in the US? ▼
What drugs does Amanda Maguschak, CNP prescribe most often? ▼
Does Amanda Maguschak, CNP accept Medicare? ▼
How can I verify Amanda Maguschak, CNP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology